ALX Oncology Holdings Inc.ALXONASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
26.36%
↑ 232% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-19.91%
Historical baseline
PeriodValue
202526.36%
202431.02%
2023-23.43%
2022-46.38%
2021-61.72%
2020-45.45%
2019-39.68%
20180.00%